Filed: 2/10/2023ACC: 0000921895-23-000405
📋 What this filing means
MEMORIAL SLOAN KETTERING CANCER CENTER filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $30.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$30.31M
Total AUM (reported)
2.08M
Total Shares
Allocation by class
GOLD MINERS ETF$21.17M69.8%
COM$9.15M30.2%
Portfolio Concentration
Top 3$28.13M92.8%
4–10$2.18M7.2%
Top 3 weight
92.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.08M
Sole
Full voting authority
2.08M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
VANECK ETF TRUST
SOLEShares738.50K
TypeSH
Market value$21.17M
69.82%
Sole
738.50K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares602.27K
TypeSH
Market value$3.55M
11.70%
Sole
602.27K
Shared
0.00
None
0.00
CARIBOU BIOSCIENCES INC
SOLEShares544.20K
TypeSH
Market value$3.42M
11.27%
Sole
544.20K
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares6.19K
TypeSH
Market value$1.25M
4.13%
Sole
6.19K
Shared
0.00
None
0.00
Y-MABS THERAPEUTICS INC
SOLEShares191.18K
TypeSH
Market value$932.9K
3.08%
Sole
191.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VANECK ETF TRUSTSOLE | GOLD MINERS ETF | 738.50K | SH | $21.17M 69.82% | 738.50K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 602.27K | SH | $3.55M 11.70% | 602.27K | 0.00 | 0.00 |
CARIBOU BIOSCIENCES INCSOLE | COM | 544.20K | SH | $3.42M 11.27% | 544.20K | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 6.19K | SH | $1.25M 4.13% | 6.19K | 0.00 | 0.00 |
Y-MABS THERAPEUTICS INCSOLE | COM | 191.18K | SH | $932.9K 3.08% | 191.18K | 0.00 | 0.00 |